Blueberry-derived compound shows promise in enhancing colonic mucosal barrier function

A research team from Shenyang Agricultural University, led by Dr. Bin Li, has highlighted the potential of malvidin-3-O-galactoside (M3G), a blueberry-derived anthocyanin, to improve colonic mucosal barrier function and alleviate colitis symptoms. They demonstrated that M3G enhances the integrity of the colonic barrier by regulating key proteins and Notch signaling pathways, suggesting its potential as a natural therapeutic agent for intestinal diseases.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca